Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled, Double Blind Trial to Evaluate Sedation and Quality of Life in High-risk, Critically Ill Patients Treated With Oral Melatonin

NCT00470821 is registered in ClinicalTrials.gov with University of Milan as lead sponsor.

NCT NCT00470821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00470821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled, Double Blind Trial to Evaluate Sedation and Quality of Life in High-risk, Critically Ill Patients Treated With Oral Melatonin
Lead sponsor
University of Milan
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2007
Completion date
May 31, 2010
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill patients, mechanically ventilated patients